# Ciprofloxacin

NDC: 65862-078
Generic name: Ciprofloxacin Hydrochloride
Labeler / Manufacturer: Aurobindo Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20070426
Marketing ended: 20270131
FDA application: ANDA077859

## Active ingredients

- CIPROFLOXACIN HYDROCHLORIDE: 750 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65862-078"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65862-078
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2b3b6a9f-259c-4736-b88f-f49d1eb64286